APOE and dementia: Further, possession of the ApoE-ε4 allele is associated with worse cognitive performance in old age [32] and greater risk of cognitive decline and dementia [33], hence, even in cognitively healthy samples screened for dementia, the genesis of any cognitive change may differ between carriers and non-carriers, providing another potential avenue for differential effects of supplementation on cognitive outcomes due to ApoE genotype.